SCHEMBL3699604

SCHEMBL3699604

Cc1ccc(S(=O)(=O)N(C2CCCCC2)C2CCCCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.54
CNR1 P21554 2/20 0.52
CNR2 P34972 2/20 0.52
ALDH1A1 P00352 7/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 1/20 0.51
CYP3A4 P08684 1/20 0.51
TSHR P16473 1/20 0.51
LMNA P02545 1/20 0.51
GAA P10253 1/20 0.51
HTR2A P28223 1/20 0.50
HTR2C P28335 1/20 0.50
MAPT P10636 2/20 0.48
ACHE P22303 1/20 0.47
AGER Q15109 1/20 0.47
NPSR1 Q6W5P4 3/20 0.47
TP53 P04637 2/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9303072 0.84 ALDH1A1 (0.73) POLBCNR1CNR2ALDH1A1MEN1
SCHEMBL11116465 0.83 CNR1 (0.50) POLBCNR1CNR2ALDH1A1MEN1
SCHEMBL3280160 0.83 POLB (0.54) POLBCNR1CNR2ALDH1A1MEN1
SCHEMBL2336654 0.82 POLB (0.54) POLBALDH1A1MEN1KMT2AKDM4E
SCHEMBL8349997 0.81 ALDH1A1 (0.69) POLBALDH1A1MEN1KMT2AKDM4E
SCHEMBL11708553 0.81 CNR1 (0.49) POLBCNR1CNR2ALDH1A1MEN1
SCHEMBL11709606 0.81 CNR1 (0.49) POLBCNR1CNR2ALDH1A1MEN1
SCHEMBL29165184 0.80 CNR1 (0.48) POLBCNR1CNR2ALDH1A1MEN1
SCHEMBL11710002 0.79 CNR1 (0.48) POLBCNR1CNR2ALDH1A1MEN1
SCHEMBL11705624 0.79 CNR1 (0.48) POLBCNR1CNR2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640780-B1 UV CURABLE ANHYDRIDE-MODIFIED POLY(ISOBUTYLENE) 3M INNOVATIVE PROPERTIES CO (US) 2018-05-09 EP disclosed
US-9217050-B2 Crosslinkable composition comprising photobase generators 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-12-22 US disclosed
US-20150232596-A1 CROSSLINKABLE COMPOSITION COMPRISING PHOTOBASE GENERATORS 3M INNOVATIVE PROPERTIES COMPANY 2015-08-20 US disclosed
EP-2834313-A1 CROSSLINKABLE COMPOSITION COMPRISING PHOTOBASE GENERATORS 3M Innovative Properties Company (US) 2015-02-11 EP disclosed
US-8673996-B2 UV curable anhydride-modified poly(isobutylene) 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-03-18 US disclosed
WO-2013151739-A1 CROSSLINKABLE COMPOSITION COMPRISING PHOTOBASE GENERATORS 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-10-10 WO disclosed
EP-2640780-A1 UV CURABLE ANHYDRIDE-MODIFIED POLY(ISOBUTYLENE) 3M Innovative Properties Company (US) 2013-09-25 EP disclosed
US-8263808-B2 Method for deprotecting aryl or alkyl sulfonamides of primary or secondary amines SIGNA CHEMISTRY, INC. (US) 2012-09-11 US disclosed
US-8263808-B2 Method for deprotecting aryl or alkyl sulfonamides of primary or secondary amines SIGNA CHEMISTRY, INC. (US) 2012-09-11 US disclosed
WO-2012067741-A1 UV CURABLE ANHYDRIDE-MODIFIED POLY(ISOBUTYLENE) 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-05-24 WO disclosed
US-20120123011-A1 UV CURABLE ANHYDRIDE-MODIFIED POLY(ISOUTYLENE) 3M INNOVATIVE PROPERTIES COMPANY 2012-05-17 US disclosed
US-20090306391-A1 METHOD FOR DEPROTECTING ARYL OR ALKYL SULFONAMIDES OF PRIMARY OR SECONDARY AMINES SIGNA CHEMISTRY, LLC (US) 2009-12-10 US disclosed
US-20090306391-A1 METHOD FOR DEPROTECTING ARYL OR ALKYL SULFONAMIDES OF PRIMARY OR SECONDARY AMINES SIGNA CHEMISTRY, LLC (US) 2009-12-10 US disclosed
EP-2035465-A2 METHOD FOR DEPROTECTING ARYL OR ALKYL SULFONAMIDES OF PRIMARY OR SECONDARY AMINES SIGNA CHEMISTRY LLC (US) 2009-03-18 EP disclosed
WO-2007095276-A2 METHOD FOR DEPROTECTING ARYL OR ALKYL SULFONAMIDES OF PRIMARY OR SECONDARY AMINES SIGNA CHEMISTRY, LLC (US) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306391-A1 METHOD FOR DEPROTECTING ARYL OR ALKYL SULFONAMIDES OF PRIMARY OR SECONDARY AMINES ARSA, KCNJ1, SIK3 POLB 1867/4885CNR1 1477/4885CNR2 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.